Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?

about

Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?

Item

http://www.wikidata.org/entity/Q57169367

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Pancreatic, periampullary and ...... r resection in selected cases?

@en

Pancreatic, periampullary and ...... r resection in selected cases?

@nl

type

Item

label

Pancreatic, periampullary and ...... r resection in selected cases?

@en

Pancreatic, periampullary and ...... r resection in selected cases?

@nl

prefLabel

Pancreatic, periampullary and ...... r resection in selected cases?

@en

Pancreatic, periampullary and ...... r resection in selected cases?

@nl

P1476

Pancreatic, periampullary and ...... r resection in selected cases?

@en

P2093

Guy Maddern

http://www.w3.org/2001/XMLSchema#string

Harsh Kanhere

http://www.w3.org/2001/XMLSchema#string

Markus Trochsler

http://www.w3.org/2001/XMLSchema#string

Rachael Chang Lee

http://www.w3.org/2001/XMLSchema#string

Timothy J Price

http://www.w3.org/2001/XMLSchema#string

Vy Broadbridge

http://www.w3.org/2001/XMLSchema#string

P2860

Surgery for oligometastasis of pancreatic cancer

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas.

The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.

Hepatic resection: effective treatment for primary and secondary tumors.

P304

211-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4251/WJGO.V10.I8.211

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30147847

http://www.w3.org/2001/XMLSchema#string

P932

6107475

http://www.w3.org/2001/XMLSchema#string